SAB Biotherapeutics Downside Variance
| SABS Stock | | | USD 4.28 0.48 12.63% |
Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target. Below is SAB Biotherapeutics's current Downside Variance with peer comparisons and related risk metrics.
Current Downside Variance Value
At 16.4, SAB Biotherapeutics's Downside Variance indicates elevated price variability. This places SAB Biotherapeutics toward the higher end of the volatility range for Stock.
Downside Variance | = | SUM(RET DEV)2N(ER) |
| = | 16.4 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual returns deviation over selected period |
| N(ER) | = | Number of points with returns less than expected return for the period |
Downside Variance Peers Comparison
The peer group averages 163.05 for Downside Variance, with SAB Biotherapeutics at 16.4 falling below that level. Readings span 4.78 (Boundless Bio Common) to 984.97 (Iterum Therapeutics PLC). SAB Biotherapeutics has exhibited less price dispersion than the peer average over the measured period.
Downside Variance Relative To Other Indicators
The chart below plots Downside Variance against Maximum Drawdown for SAB Biotherapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Downside Variance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Downside Variance (
16.40 ) to Maximum Drawdown (
21.29 ) for SAB Biotherapeutics yields a
1.30 multiple. This indicates Maximum Drawdown moderately exceeds Downside Variance for SAB Biotherapeutics.
Methodology, Assumptions & Data Sources
The current Downside Variance for SAB Biotherapeutics is 16.4. This Downside Variance reading for SAB Biotherapeutics results from applying the indicator's calculation rules to price and volume data over the selected window. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators